At A Glance
Name: Tim Kish
Title: Vice president, CFO, Illumina
Background: VP, Finance, for Biogen; Finance Director, Allied Health & Science
Education: BBA, Michigan State University; MBA, University of Massachusetts
Over the past several quarters, this has been the prevailing theory of the future of SNP-genotyping industry: There’s no longer room in the market for pure-play genotyping instrument or services shops.